drugset / Trial / NCT05886088
Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of LID104 in the treatment of type 2 diabetes mellitus.
Timeline
- Start
- 2024-02
- Primary completion
- 2026-05
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | — | — |
| Subject | LID104 | Unknown | — | — |
| Comparator | Linagliptin | Small molecule | — | — |